Resultados de la búsqueda 521-530 de 3473 para anti-TNF drugs
The goal of this clinical research study is to learn how often breast cancer recurs (returns after treatment) in the breast in patients who have been treated ...
The tumors caused by schwannomatosis usually are not cancerous. Symptoms can include headaches, hearing loss, trouble with balance and pain. Treatment focuses ...
A Registry for Children Treated with Proton Radiation Therapy. Rochester, Minn. The purpose of the Pediatric Proton Consortium Registry (PPCR) is to enroll ...
... Therapy Treatment for a Brain Tumor. Rochester, Minn. This phase III trial compares memantine to usual treatment in treating patients with brain tumors that ...
Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes. A Study to Evaluate the ...
Drugs used in chemotherapy, such as carboplatin, cisplatin, and etoposide ... therapy selection tool for systemic therapy in CRC peritoneal disease. A ...
The aim of this study is to create a patient and patient-advocate catalyzed tumor bank for the retrieval, processing, analysis, and maintenance of pre-treatment ...
https://www.arthritis.org/drug-guide/medication-topics/topical-nsaids-offer-joint-pain-relief. Accessed April 17, 2023. Deveza LA, et al. Management of knee ...
The purpose of this study is to evaouate how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation ...
... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?